3-Chloropropiophenone CAS 936-59-4 Purity ≥99.5% (GC) Factory High Purity

Short Description:

Chemical Name: 3-Chloropropiophenone 

CAS: 936-59-4

Appearance: White Crystals or White Powder

Purity: ≥99.0% (GC) 

Intermediate of Dapoxetine Hydrochloride (CAS: 129938-20-1) in the treatment of Premature Ejaculation in Men (PE)

Enquiry: alvin@ruifuchem.com

 


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name 3-Chloropropiophenone
Synonyms 3-Chloro-1-Phenyl-1-Propanone
CAS Number 936-59-4
CAT Number RF-PI152
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C9H9ClO
Molecular Weight 168.62  
Condition to Avoid Moisture Sensitive
Melting Point 46.0~50.0℃
Boiling Point 147℃/14 mmHg
Solubility  Soluble in Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White Crystals or White Powder 
Purity / Analysis Method ≥99.5% (GC)
Phenyl Acetone ≤0.10%
2-Chloropropiophenone ≤0.10%
4'-Chloropropiophenone ≤0.10%
3'-Bromopropiophenone ≤0.10%
3,5-Dichlorobenzene Acetone ≤0.10%
3,4'-Dichloropropiophenone ≤0.10%
Single Unknown Impurity ≤0.10%
All Unknown Impurities ≤1.0%
Moisture (K.F) ≤0.50%
Test Standard Enterprise Standard
Usage Intermediate of Dapoxetine Hydrochloride (CAS 129938-20-1)

Package & Storage:

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

2

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 3-Chloropropiophenone (CAS: 936-59-4) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) synthesis. 

3-Chloropropiophenone (CAS: 936-59-4) can be used in the synthesis of Dapoxetine Hydrochloride (CAS: 129938-20-1). Dapoxetine Hydrochloride (CAS: 129938-20-1) is a short-acting novel selective serotonin reuptake inhibitor marketed for the treatment of premature ejaculation in men. Premature ejaculation (PE) is the most common male sexual disorder, estimated to affect up to 30% of men.  

  • Write your message here and send it to us